Close Window

Digital Look Email A Friend

Bioventix profits shoot higher on vit-D tests, but may plateau

Published by Iain Gilbert on 16th October 2017

(ShareCast News) - Biotech group Bioventix lifted annual pre-tax profits by more than a third as revenue was boosted by a significant increase in sales of its vitamin D antibody.


Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.